05/27/2025
7:15 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/22/2025
7:00 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/13/2025
7:24 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/06/2025
6:43 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/28/2025
7:36 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/17/2025
7:45 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/15/2025
8:04 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/10/2025
7:09 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/08/2025
11:15 PM | Galmed Pharmaceuticals (Filer)
| Form EFFECT | |
01/07/2025
3:16 PM | Galmed Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/21/2024
11:15 PM | Galmed Pharmaceuticals (Filer)
| Form EFFECT | |
Get the Latest News and Ratings for GLMD and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Galmed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
11/14/2024
11:24 AM | CVI Investments, Inc. (Filed by)
Galmed Pharmaceuticals (Subject)
| Form SC 13G/A | |
10/28/2024
11:15 PM | Galmed Pharmaceuticals (Filer)
| Form EFFECT | |
10/28/2024
3:30 PM | Galmed Pharmaceuticals (Filer)
| Form 424B3 | |
10/21/2024
3:16 PM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/21/2024
3:20 PM | Galmed Pharmaceuticals (Filer)
| Form F-1
Registration statement for securities of certain foreign private issuers | |
10/15/2024
3:15 PM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/25/2024
7:05 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/20/2024
3:46 PM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/20/2024
1:17 PM | Galmed Pharmaceuticals (Subject)
Otsuka Masaya (Filed by)
| Form SC 13G | |
09/20/2024
1:18 PM | Galmed Pharmaceuticals (Subject)
Otsuka Masaya (Filed by)
| Form SC 13G/A | |
09/19/2024
6:13 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/09/2024
11:15 PM | Galmed Pharmaceuticals (Filer)
| Form EFFECT | |
09/09/2024
3:30 PM | Galmed Pharmaceuticals (Filer)
| Form 424B3 | |
08/30/2024
3:25 PM | Galmed Pharmaceuticals (Filer)
| Form F-1
Registration statement for securities of certain foreign private issuers | |
08/28/2024
3:30 PM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/27/2024
3:15 PM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/18/2024
3:30 PM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/11/2024
7:50 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
